Related Experiment Videos

Interleukins modulate glucocorticoid-induced thymocyte apoptosis

G Migliorati1, C Pagliacci, R Moraca

  • 1Institute of Pharmacology, School of Medicine, University of Perugia, Italy.

International Journal of Clinical & Laboratory Research
|January 1, 1992
PubMed

Insights

Interleukins 1 alpha, 2, and 4 inhibit glucocorticoid-induced apoptosis in mouse thymocytes, crucial for T-cell development. Interleukin-4 shows the most potent inhibition, highlighting its role in regulating thymic selection.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Apoptosis, or programmed cell death, is vital for T-cell development and deletion of autoreactive cells during thymic maturation.
  • Glucocorticoids and calcium ionophores are known inducers of thymocyte apoptosis, a process implicated in negative selection.

Purpose of the Study:

  • To investigate the modulatory effects of various cytokines on glucocorticoid-induced apoptosis in mouse thymocytes.
  • To determine the relative potency of different interleukins in inhibiting dexamethasone-induced apoptosis.

Main Methods:

  • In vitro culture of mouse thymocytes.
  • Induction of apoptosis using dexamethasone (a glucocorticoid) and other agents.
  • Assessment of apoptosis via DNA fragmentation.
  • Dose-response studies with various interleukins.

Main Results:

  • Interleukin-1 alpha, interleukin-2, and interleukin-4 significantly inhibited dexamethasone-induced apoptosis.
  • Interleukin-4 demonstrated greater potency than interleukin-1 alpha and interleukin-2.
  • Interleukin-4 also inhibited apoptosis induced by a protein kinase-C activator but not by a calcium ionophore.

Conclusions:

  • Interleukins, particularly interleukin-4, act as crucial modulators of the negative selection process in the thymus.
  • These findings suggest a regulatory role for interleukins in controlling T-cell maturation and preventing autoimmunity.

Related Concept Videos